Clinical Trial

Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years

Name: Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years — clinical trial record (NCT06715891)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Multicenter double-blind placebo-controlled randomized in parallel groups clinical trial.

Protocol Amendment History 4 amendments

This ClinicalTrials.gov record has been amended 4 times since 2024-11-29; most recent amendment 2026-03-11.

Trial Details

NCT Number	NCT06715891
Lead Sponsor	Materia Medica Holding
Conditions	Acute Respiratory Viral Infection
Enrollment	374 participants
Start Date	2024-11-11
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-13